26 related articles for article (PubMed ID: 12856804)
1. MRI for the detection of prostate cancer origin vertebral metastases in the preosteoblastic phase.
Revannasiddaiah S; Rastogi M; Thakur P; Gupta MK; Sood A; Sharma C
BMJ Case Rep; 2012 Jul; 2012():. PubMed ID: 22778472
[TBL] [Abstract][Full Text] [Related]
2. Bright spine.
Ogushi A; Sugioka T; Nishiyama M
J Gen Fam Med; 2018 May; 19(3):113-114. PubMed ID: 29744267
[TBL] [Abstract][Full Text] [Related]
3. Editorial Comment on "Poor Bone Mineral Density is Associated with Increased Risk of Urological Bone Metastases".
Singla N
Urology; 2024 Jun; ():. PubMed ID: 38830556
[No Abstract] [Full Text] [Related]
4. Bone mineral density for patients with bone metastasis of prostate cancer: a preliminary report.
Tanaka H; Furukawa Y; Fukunaga K; Fukunaga M
Adv Exp Med Biol; 1992; 324():217-31. PubMed ID: 1492619
[TBL] [Abstract][Full Text] [Related]
5. Assessment of bone turnover markers and DXA parameters to predict bone metastasis progression during zoledronate treatment: a single-center experience.
D'Oronzo S; Cives M; Lauricella E; Stucci S; Centonza A; Gentile M; Ostuni C; Porta C
Clin Exp Med; 2024 Jan; 24(1):7. PubMed ID: 38240866
[TBL] [Abstract][Full Text] [Related]
6. Predicting Fractures Using Vertebral 18F-NaF Uptake in Prostate Cancer Patients.
Chesnais H; Bastin N; Miguez S; Kargilis D; Kalluri A; Terry A; Rajapakse CS
J Bone Metab; 2023 Nov; 30(4):329-337. PubMed ID: 38073266
[TBL] [Abstract][Full Text] [Related]
7. A Randomised Comparison Evaluating Changes in Bone Mineral Density in Advanced Prostate Cancer: Luteinising Hormone-releasing Hormone Agonists Versus Transdermal Oestradiol.
Langley RE; Kynaston HG; Alhasso AA; Duong T; Paez EM; Jovic G; Scrase CD; Robertson A; Cafferty F; Welland A; Carpenter R; Honeyfield L; Abel RL; Stone M; Parmar MK; Abel PD
Eur Urol; 2016 Jun; 69(6):1016-25. PubMed ID: 26707868
[TBL] [Abstract][Full Text] [Related]
8. The Association of Endothelin-1 Signaling with Bone Alkaline Phosphatase Expression and Protumorigenic Activities in Canine Osteosarcoma.
Neumann ZL; Pondenis HC; Masyr A; Byrum ML; Wycislo KL; Fan TM
J Vet Intern Med; 2015; 29(6):1584-94. PubMed ID: 26426813
[TBL] [Abstract][Full Text] [Related]
9. Diffuse osteosclerosis in a patient with prostate cancer.
Ustün N; Ustün I; Ozgür T; Atci N; Aydoğan F; Sümbül AT; Turhanoğlu AD
Osteoporos Int; 2014 Mar; 25(3):1181-5. PubMed ID: 24136106
[TBL] [Abstract][Full Text] [Related]
10. Role of pigment epithelium-derived factor in stem/progenitor cell-associated neovascularization.
Liu JT; Chen YL; Chen WC; Chen HY; Lin YW; Wang SH; Man KM; Wan HM; Yin WH; Liu PL; Chen YH
J Biomed Biotechnol; 2012; 2012():871272. PubMed ID: 22685380
[TBL] [Abstract][Full Text] [Related]
11. Correlation between BMD and bone scintigraphy in patients with prostate cancer.
Perk H; Yildiz M; Kosar A; Cerci S; Soyupek F; Ozorak A; Dilmen C
Urol Oncol; 2008; 26(3):250-3. PubMed ID: 18452814
[TBL] [Abstract][Full Text] [Related]
12. Antecedent 99mTc-MDP and 99mTc-sestamibi administration corrupts bone mineral density measured by DXA.
McKiernan FE; Hocking J; Cournoyer S
J Clin Densitom; 2006; 9(2):164-6. PubMed ID: 16785076
[TBL] [Abstract][Full Text] [Related]
13. Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions.
Savelli G; Maffioli L; Maccauro M; De Deckere E; Bombardieri E
Q J Nucl Med; 2001 Mar; 45(1):27-37. PubMed ID: 11456373
[TBL] [Abstract][Full Text] [Related]
14. Lumbar bone mineral density in prostate cancer patients with bone metastases.
Chang CH; Tsai CS; Jim YF; Wu HC; Lin CC; Kao A
Endocr Res; 2003 May; 29(2):177-82. PubMed ID: 12856804
[TBL] [Abstract][Full Text] [Related]
15. Is bone mineral density measurement using dual-energy X-ray absorptiometry affected by gamma rays?
Xie LJ; Li JF; Zeng FW; Jiang H; Cheng MH; Chen Y
J Clin Densitom; 2013; 16(3):275-278. PubMed ID: 23473956
[TBL] [Abstract][Full Text] [Related]
16. Quantification evaluation of
Huang K; Feng Y; Liu D; Liang W; Li L
Ann Nucl Med; 2020 Feb; 34(2):136-143. PubMed ID: 31768820
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
